
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
DGLA (Dihomo-Gamma-Linolenic Acid) is an omega-6 fatty acid that produces anti-inflammatory prostaglandin E1 (PGE1) through cyclooxygenase conversion. Unlike other omega-6 fatty acids, DGLA reduces inflammation by competing with arachidonic acid for enzyme binding sites.

Reported Benefits (Provisional)
Origin & History

DGLA, or dihomo-gamma-linolenic acid, is an omega-6 fatty acid found in small amounts in animal fats and some plant oils. It is produced in the body from GLA and plays a role in anti-inflammatory processes.
Research Narrative (Provisional)
Preliminary research, including in vitro studies, suggests DGLA's potential in supporting anti-inflammatory and cardiovascular health. Its role in the metabolism of GLA is being explored.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Contains omega-6 fatty acids, particularly DGLA. - Acts as an intermediate in the metabolism of GLA. - Found in small amounts in animal fats and some plant oils.
Reported Mechanism (Provisional)
DGLA converts to prostaglandin E1 (PGE1) via cyclooxygenase-1 and cyclooxygenase-2 enzymes, producing anti-inflammatory effects. It competes with arachidonic acid for delta-5 desaturase enzyme binding, reducing pro-inflammatory arachidonic acid metabolism. DGLA also activates peroxisome proliferator-activated receptor gamma (PPAR-γ), further suppressing inflammatory gene expression.
Clinical Narrative (Provisional)
Small-scale studies with 20-60 participants show DGLA supplementation reduces inflammatory markers like IL-6 and TNF-α by 20-30% over 8-12 weeks. Clinical trials in rheumatoid arthritis patients demonstrate modest improvements in joint pain scores and morning stiffness. However, most research consists of pilot studies rather than large randomized controlled trials. Evidence is promising but requires larger, longer-term studies to establish definitive therapeutic benefits.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







